Gordon Research Conferences
Meeting Details

New Antibacterial Discovery and Development
Gordon Research Conference

Driving Antibacterial Discovery and Development to Address the Clinical Demands of the Next Decade


March 11-16, 2018


Ventura Beach Marriott
Ventura, CA Site Information


Richard E. Lee & Terry Roemer

Vice Chairs:
Ruben A. Tommasi & Matthew A. Cooper

Application Deadline

Applications for this meeting must be submitted by February 11, 2018. Please apply early, as some meetings become oversubscribed (full) before this deadline. If the meeting is oversubscribed, it will be stated here. Note: Applications for oversubscribed meetings will only be considered by the Conference Chair if more seats become available due to cancellations.

Meeting Description

The 2018 Gordon Research Conference on New Antibacterial Discovery and Development will bring highly experienced leaders in antibacterial drug discovery and development together with young investigators and those new to the field of antibiotics research in order to enable the next generation of safe and effective drugs. Discussion leaders and speakers are chosen from academia, industry, and government agencies to emphasize the breadth of talent and leadership necessary to drive innovation around target discovery and validation, hit identification and chemical optimization, and clinical trial design and execution. Previous meetings have defined the problem of antibiotic resistance, the challenges in antibiotic discovery and development faced over the past two decades, and the need for new pathways for clinical development. Those meetings have successfully created a community of idea generation and collaboration in what is otherwise a highly competitive scientific arena. This meeting will build on those foundations by exploring 1) novel strategies for achieving potent and safe antibacterial drugs against the most difficult-to-treat organisms, 2) new approaches for monitoring infections with the goal of broadening the opportunities for clinical development, and 3) learning from recent clinical programs with new and established targets which may be translatable to the next generation of antibacterial drugs.

Related Meeting

This GRC will be held in conjunction with the "New Antibacterial Discovery and Development" Gordon Research Seminar (GRS). Those interested in attending both meetings must submit an application for the GRS in addition to an application for the GRC. Refer to the associated GRS program page for more information.


Gordon Research Conferences

Preliminary Program

The topics and speakers for the conference sessions are displayed below (italics denote discussion leaders). The Conference Chair is currently developing their detailed program, which will include the complete meeting schedule, as well as the talk titles for all speakers. The detailed program will be available by November 11, 2017. Please check back for updates.

  • Keynote Session: Critical Lessons of the Past and Their Application to Modern Antibacterial Drug Discovery and Development
    (Karen Bush / Patricia Bradford / Chris Walsh)
  • The Clinical Reality – Single Agent Therapeutics and Antibacterial Drug Resistance: Examining the Need for New Therapeutic Options in the Clinic
    (Louis Rice / Brad Spellberg / Romney Humphries / Jason Rosch / Julian Hurdle)
  • Twenty First Century Natural Product-Based Antibiotic Discovery
    (Lynn Silver / Bradley Moore / Laurence Reid / Gerry Wright)
  • Gram-Negative Outer Membrane Biogenesis – Targeting Intrinsic Resistance
    (Alita Miller / Daniel Kahne / Natividad Ruiz / Adrian Jubb)
  • Moving Past Rules: Re-Examining Chemical Design Strategies for Antibacterial Agents
    (Heinz Moser / Thomas Durand-Reville / Paul Hergenrother / Peter Tonge)
  • Novel Antibacterial Agents and Alternative Approaches / Late-Breaking Topics
    (Heike Broetz-Oesterhelt / Shahriar Mobashery / Cuong Vuong / Deborah Hung / Erik Boettger)
  • Antibacterial Agents for Difficult to Eradicate Infections
    (Kim Lewis / Clifton Barry / Michael LaFleur / Raymond Schuch)
  • Emerging Therapeutic Candidates in the Clinical Development Pipeline
    (George Drusano / Jennifer Leeds / Jacques Dumas)
  • Keynote Session: Antibacterial Drug Discovery and Development in the Next Decade
    (Laura Piddock / Michael Dudley / Steven Projan / John Rex)
© 2017 Gordon Research Conferences Search | Contact | Terms of Use | Privacy Policy | Follow us: Facebook Twitter